PharmaLex Group has added Sébastien Schmitt to the company’s senior management team.
Schmitt joins PharmaLex as Chief Commercial Officer where he will oversee all aspects of PharmaLex commercial activities.
Through his role, he will ensure that PharmaLex further strengthens the commercial fundamentals, strategy, operations and a team dynamic that will be designed to grow with our clients’ needs. He will also develop the PharmaLex Swiss country organization as its Managing Director.
Schmitt joins PharmaLex following nearly a decade with ProductLife Group, where he headed the delivery and commercial organization.
“I am very excited to join a growing organization like PharmaLex”, Schmitt said. “Their reputation as a leader in specialized services for the life science industry is well known and their global footprint presents excellent opportunities to provide real added value to their clients”, he commented.
“We are extremely pleased that Sébastien is joining us to head and further shape our commercial organisation. His ability to deliver customer-focused and results-oriented solutions was key during the selection process”, said Dr. Thomas Dobmeyer, CEO PharmaLex. “Furthermore, we have seen a very positive development in the entire DACH region and strengthening our location in Switzerland will be of particular strategic importance, ensuring that our services can be expanded to the hotspot of the Swiss pharmaceutical industry.”